ROS‐Triggered Microgels for Programmable Drug Release in Volumetric Muscle Loss Repair
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202502203 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Seungjun Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Materials Science and Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju, 61005, Republic of Korea. Hauptthemen laut MEDLINE: Curcumin, Reactive Oxygen Species, Microgels, Muscle, Skeletal. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Science, ICT, and Future Planning, InnoCORE program of the Ministry ofScience and ICT.
Abstract (Originalsprache)
Volumetric muscle loss (VML), frequently resulting from traumatic or surgical damage, causes significant muscle mass depletion and fibrosis, and presents major challenges to effective regeneration. In this study, reduced graphene‐containing hyaluronic acid microgels (rGHMs) are developed as a multifunctional platform for reactive oxygen species (ROS)‐scavenging and ROS‐responsive drug delivery to treat VML. The rGHMs are synthesized via a water‐in‐oil emulsion and subsequent chemical reduction. rGHMs demonstrate superior antioxidative capability, curcumin loading efficiency, and ROS‐mediated drug release properties compared to HA microgels (HMs) and unreduced graphene‐oxide containing HA microgels (GHMs). In particular, curcumin‐loaded rGHMs (Cur/rGHMs) significantly facilitate curcumin release with a 2.6‐fold increase under 1 m m H 2 O 2 compared to non‐ROS conditions, demonstrating programmable, ROS‐triggered release kinetics. In vitro studies confirm that rGHMs are cytocompatible and protect C2C12 myoblasts from ROS‐induced damage. In vivo studies using a mouse VML model reveal that Cur/rGHMs significantly enhance skeletal muscle regeneration, as evidenced by an increased number of centronucleated muscle cells, 89.0 % muscle strength recovery, 51.0 % reduction in fibrosis, a 2.3‐fold increase in vascularization, and attenuated inflammatory macrophage infiltration. These ROS‐responsive microgels enable programmed curcumin delivery in oxidative environments, offering a promising therapeutic strategy for skeletal muscle regeneration in VML.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Materials Science and Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju, 61005, Republic of Korea.
ORCID-Profile: Jae Young Lee
Förderung
- National Research Foundation of Korea
- Ministry of Science, ICT, and Future Planning
- InnoCORE program of the Ministry ofScience and ICT
Zitieren
APA
Lee, S., Choe, G., Kim, J., Park, J., Kok, J. Y. E., & Lee, J. Y. (2026). ROS‐Triggered Microgels for Programmable Drug Release in Volumetric Muscle Loss Repair. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202502203
Vancouver
Lee S, Choe G, Kim J, Park J, Kok JYE, Lee JY. ROS‐Triggered Microgels for Programmable Drug Release in Volumetric Muscle Loss Repair. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202502203
BibTeX
@article{Lee2026,
author = {Lee, Seungjun and Choe, Goeun and Kim, Junghyun and Park, Junggeon and Kok, Jia Yi Erica and Lee, Jae Young},
title = {ROS‐Triggered Microgels for Programmable Drug Release in Volumetric Muscle Loss Repair},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202502203}
}
EUVIMED